NCT05177939: Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis |
|
|
| Recruiting | 3 | 40 | Japan | NPB-01, Intravenous immunoglobulin, NPB-01-ME, methylprednisolone sodium succinate | Nihon Pharmaceutical Co., Ltd | Autoimmune Encephalitis | 05/24 | 10/24 | | |